Stay updated on Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page.

Latest updates to the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe page’s revision/version label in the footer has been updated from v3.5.2 to v3.5.3, reflecting a technical/site update rather than a change to the study information.SummaryDifference0.0%

- Check25 days agoChange DetectedAdded Araucania and Temuco, Araucania, Chile, 4800827. Added Bucharest; updated Temuco, Región de la Araucanía, Chile, 4800827 to Temuco, Araucania, Chile, 4800827 and București to Bucharest; revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check54 days agoChange DetectedNapoli, Italy 80131 was replaced with Naples, Italy 80131 in the location list, and the revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check61 days agoChange DetectedThe study status was updated to Completed with a completion date of 2026-01-20; the previous Active, not recruiting status was removed.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check89 days agoChange DetectedRevision updated to v3.4.2. Previous revision v3.4.1 has been removed.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page.